Carbon Reduction Plan

Document control

Document Control

Executive summary

Executive Summary

Basis of preparation

Basis of Preparation and NHS Requirements

This Carbon Reduction Plan (CRP) has been prepared for AIRS Medical Europe GmbH as the supplier engaging with the NHS. It follows the structure and core content expected under PPN 006 and the NHS Carbon Reduction Plan requirements: it identifies the current carbon footprint, sets an emissions baseline, states a Net Zero commitment, discloses Scope 1, Scope 2 and the required subset of Scope 3 emissions, and describes the environmental management measures currently being implemented, and to be implemented, to reduce carbon emissions.

Reporting boundary

Organisational and Reporting Boundary

This CRP is prepared in line with the Greenhouse Gas (GHG) Protocol Corporate Accounting and Reporting Standard using the operational control consolidation approach. AIRS Medical Europe GmbH reports emissions from sources or factors over which it has operational control and relevant to its operations. We capture our own Scope 1 and Scope 2 carbon emissions from our offices, and other direct activities. In addition, we use work activities, purchases, supplier specific data and procurement spend data to calculate and estimate Scope 3 emissions. All data is associated with a project or activity, allowing us a level of detail that informs project level activities as well as our strategic approach to carbon reduction.

• Bidding / contracting entity: AIRS Medical Europe GmbH, incorporated in Munich, Germany, is the entity expected to hold the contractual relationship with the NHS.
• Geographic boundary: AIRS Medical Europe GmbH has no UK-based operations. As a non-UK supplier, this CRP reports the full organisational footprint of the German bidding entity rather than limiting the report to territorial UK emissions.
• Operational boundary: The plan includes direct fuel use from the company vehicle, confirms that the entity has no controlled metered electricity supply, and reports the required Scope 3 categories: upstream transportation and distribution, waste generated in operations, business travel, employee commuting including home-working, and downstream transportation and distribution.
• Phased boundary expansion: From the next annual update for FY2026, AIRS Medical Europe GmbH intends to extend the reporting boundary to include its parent corporation, AIRS Medical, Inc. based in Seoul, Republic of Korea, and to report relevant global Scope 1, Scope 2 and Scope 3 emissions. If the boundary change materially affects comparability, the baseline will be restated and clearly labelled.
• Contract performance: The measures described in this CRP are designed to be capable of implementation while AIRS Medical Europe GmbH performs NHS contracts, including travel controls, local delivery arrangements, remote support, procurement improvements and environmental-management governance.

Commitment

Commitment to Achieving Net Zero

AIRS Medical Europe GmbH is a health-technology company supplying medical software and related support and maintenance services. As a prospective NHS supplier, we support the NHS Net Zero ambition and commit to reducing the emissions associated with our operations and value chain.

AIRS Medical Europe GmbH is committed to achieving Net Zero emissions by 2045, and by 2050 at the latest, across its organisational footprint: Scope 1, Scope 2 and Scope 3.

• This commitment is aligned with the NHS Carbon Footprint Plus target of net zero by 2045 (the boundary that includes the NHS supply chain) and goes beyond the PPN 006 minimum requirement of Net Zero by 2050;
• The commitment applies to AIRS Medical Europe GmbH and will be expanded to the global group boundary from FY 2026 as part of the next annual CRP update;
• The reduction strategy prioritises direct operational reductions, particularly business-travel reductions, fleet electrification, remote delivery, procurement controls and cloud-efficiency practices.

This is our first CRP. It will be reviewed, updated and re-published at least annually, within six months of financial year-end, and earlier if there is a material change in organisational structure, reporting boundary or emissions methodology. After committing to this plan, we will change how we conduct our business and the running of our operations, and we will implement new technologies and ways to deliver our services that decarbonise and help preserve the environment, alongside goals outlined in this plan.

Baseline footprint

Baseline Emissions Footprint

Baseline emissions are a record of the greenhouse gases produced before the introduction of any strategies to reduce emissions. They are the reference point against which emissions reduction is measured.

Baseline year is 2025, and its reporting period: 1 January 2025 to 31 December 2025. AIRS Medical Europe GmbH has not previously assessed or reported its carbon footprint; therefore, 2025 is both the baseline year and the current reporting year for this first CRP. Where activity data was incomplete or was unable to retrieve with specificity, estimates were used on a reasonable basis and are identified in the tables and methodology appendix.

As stated above, this CRP covers the bidding entity only; we plan a substantial boundary expansion to include its parent corporation from FY 2026, at which point the baseline may be restated for comparability.

Baseline Year Emissions (2025)

Scope 1 Breakdown

Scope 2 Breakdown

No Scope 2 factors were included in the baseline reporting period. Due to the methodology used, the relevant factors could not be measured because we were unable to retrieve individual records relating to our activities. We operate on a remote-first basis and uses shared serviced-office space only when needed. Building electricity and utilities are not separately metered or controlled by the entity. Shared workspace use is therefore treated as a voluntary Scope 3 Category 8 disclosure where data is available or capable of reasonable estimation. Home-working emissions are considered within Scope 3 Category 7.

The shared workspace management company also maintains its own sustainability and green policies aimed at reducing carbon emissions and improving energy efficiency.

Scope 3 Breakdown

Business travel is the dominant source, representing approximately 88% of the emissions total. Air travel alone represents approximately 57% of the total. The carbon-reduction plan therefore focuses on reducing unnecessary air travel, consolidating international travel, increasing remote delivery and shifting appropriate intra-European travel to lower-carbon modes.

Additional Voluntary Disclosures (Beyond the Mandated Subset)

Grand total including voluntary quantified disclosures: approximately 56.0 tCO2e. The emissions-reduction targets in this CRP are stated against the PPN 006 mandated scope total of 54.8 tCO2e.

Current reporting

Current Emissions Reporting

As this is our first CRP, the current reporting year is the same as the baseline year 2025. The baseline emissions figures above therefore also constitute the current reporting year emissions.

Reduction targets

Emissions Reduction Targets

In order to continue progress towards net zero, AIRS Medical Europe GmbH has adopted the following carbon-reduction targets against the 2025 baseline for the current reporting boundary.

We project that carbon emissions will decrease to approximately 41 tCO2e by 2030. This represents a reduction of approximately 25% against the 2025 baseline of 54.8 tCO2e. We will pursue a further reduction to approximately 27 tCO2e by 2035 and net zero by 2045. The reduction trajectory is based primarily on operational reductions rather than offsetting.

AIRS Medical Europe GmbH is still at an early stage of commercial expansion. Business growth may place upward pressure on carbon emissions in the short or medium terms, especially if customer delivery or regulatory activities require travel. We will manage this through both carbon emissions targets and intensity metrics, including travel tCO2e per full-time equivalent, long-haul trips per year and emissions per implementation activity.

Emissions Reduction Trajectory to Net Zero 2045

Delivery plan

How We Will Meet These Targets

The initiatives below support the 2030 target. Estimated reductions are AIRS Medical Europe GmbH management projections against the FY2025 baseline. We will measure, review and report progress annually. Each measure is intended to be applied while performing NHS contracts where relevant and proportionate.

To reach the 2035 and 2045 targets, AIRS Medical Europe GmbH will deepen the same measures, with the largest reductions expected from continued air-travel reduction, local capability, low-carbon service delivery and improved procurement and cloud-emissions data. Certified removals will be used only for residual emissions that cannot reasonably be eliminated by around 2045.

Reduction projects

Carbon Reduction Projects

Completed or already implemented measures

As 2025 is the first reporting year, quantified reductions will be reported against the baseline from the next annual update. The following measures, practices and policies are already in place and will continue to apply during performance of relevant contracts:

• Remote-first working: staff work remotely and the entity does not maintain a dedicated leased office. Shared serviced-office space is used only when needed, reducing dedicated office energy use and routine commuting.
• Sustainable IT lifecycle in practice: staff laptops are company-provided on a rental / reuse model, and returned devices are redeployed where appropriate to extend equipment life.
• Cloud-efficiency practices: right-sizing, Graviton / ARM instances, autoscaling and idle-resource management are used where technically feasible to reduce cloud-computing energy intensity.
• Reduced consumables: plastic consumables have been reduced where possible and reusable or sustainably sourced alternatives are preferred.
• Lower-carbon travel choices: employees are encouraged to use public transport instead of rental cars, private cars or hired vehicles where travel is necessary and public transport is practical.
• Travel-data capture: business travel is recorded through the corporate-card and finance systems, providing a practical basis for annual emissions tracking and policy monitoring.

Future carbon reduction initiatives

The following initiatives will be implemented or formalised during the next reporting periods:

• Formal business-travel policy: introduce a video-first and travel-approval policy, with explicit controls on long-haul travel, conference attendance and repeat trips where remote participation is practicable.
• Local hiring and local delivery: expand use of local talent, local professional networks and local implementation support to reduce the need for cross-continental travel.
• Fleet electrification: replace the current petrol company vehicle with an EV at the next appropriate rental / lease renewal and monitor vehicle emissions annually.
• ISO 14001 Environmental Management System: implement an EMS with external consultancy support, including environmental objectives, internal audit, management review and documented continual-improvement actions, with a target date of August 2026 for the initial certification / implementation milestone.
• Supplier and procurement controls: To the extent applicable, request carbon information from material suppliers and service providers, prefer lower-carbon alternatives where commercially and clinically appropriate, and consolidate logistics to reduce Cat 4 and Cat 9 emissions.
• Cloud emissions and software efficiency: To the extent applicable, obtain AWS / group-level cloud emissions data, improve utilisation metrics, and review software architecture choices that can reduce compute demand.
• Formal IT lifecycle controls: establish refresh-cycle rules, refurbished-device criteria, redeployment process and WEEE recycling records.
• Science Based Targets review: assess whether and when target validation through the Science Based Targets initiative is appropriate once the group boundary and global data set are established.
• Certified removals only as a last resort: use certified carbon removals near 2045 only for residual emissions that cannot reasonably be eliminated, not as a substitute for reductions.

Governance

Governance and Monitoring

AIRS Medical Europe GmbH will govern this CRP through management oversight, operational ownership and annual public reporting. The Managing Director has overall accountability for the CRP, supported by Business Operations, Finance, Information Security and Legal.

• Annual update: The CRP will be reviewed and updated at least annually, within six months of financial year-end, using the latest available activity data and emission factors.
• Quarterly monitoring: Key indicators will be reviewed periodically, including business-travel emissions, long-haul trips, company-vehicle emissions, office / desk-day use, commuting assumptions, IT asset lifecycle and cloud-efficiency measures.
• Management review: Progress against the emissions trajectory and the implementation plan will be reviewed by management, with corrective actions assigned to responsible owners.
• Publication: The latest CRP will be clearly signposted on AIRS Medical Europe GmbH / English web pages or otherwise made available in writing to relevant NHS contracting authorities upon request.
• Restatement policy: If the reporting boundary, calculation methodology or data quality changes materially, the affected baseline and current-year figures will be restate.

Appendix A

Appendix A - Methodology and Emission Factors

• Consolidation: GHG Protocol Corporate Accounting and Reporting Standard, operational control boundary.
• Standards: GHG Protocol Corporate Standard; Corporate Value Chain (Scope 3) Standard for Categories 4, 5, 6, 7 and 9; SECR where applicable; and the reporting standard for completion of Carbon Reduction Plans under PPN 006.
• Emission factors: UK Government GHG Conversion Factors for Company Reporting, 2025, unless a more specific supplier factor or calculation basis is stated.
• Gases: CO2, CH4, N2O, HFCs, PFCs, SF6 and NF3, reported in tonnes of carbon dioxide equivalent (tCO2e).
• Air travel: routes from 2025 corporate-card records were mapped to approximate great-circle distances and multiplied by DEFRA passenger-kilometre factors. Economy class was assumed because the company travel policy permits business class only for very long flights and no 2025 route was identified as meeting that threshold. Air travel is reported excluding radiative forcing; as a sensitivity, applying the DEFRA supplementary radiative-forcing uplift would increase air-travel emissions and the total footprint materially.
• Vehicle: one petrol company vehicle was included under Scope 1 using approximate annual mileage of 24,000 km and an average petrol-car factor. Company-car mileage is counted once under Scope 1; private-car business mileage, where applicable, is treated under Scope 3 Category 6 to avoid double-counting.
• Hotels, taxis, rental cars and other travel: estimated from expenditure where primary activity data was unavailable and flagged as estimates.
• Electricity: AIRS Medical Europe GmbH had no controlled metered electricity supply in 2025. Shared workspace use is estimated separately as a voluntary Scope 3 Category 8 disclosure.
• IT hardware: embodied-carbon estimate based on the company asset register for approximately 12 laptops in the 2025 fleet, annualised over an assumed four-year life. Devices added in 2026 will fall within the FY2026 reporting period.
• Data availability: business travel, the largest source, was taken from the corporate-card / finance system and no material outside bookings or reimbursements were identified for 2025. Where data was incomplete, estimates were used and improvement actions have been included in this CRP.
• Assurance: this CRP has not been independently assured. AIRS Medical Europe GmbH will assess whether external verification is appropriate once the reporting boundary expands and data coverage improves.